DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,248,835 | -45.4% | 250,986 | -31.4% | 0.00% | -50.0% |
| Q2 2023 | $4,115,531 | +8.9% | 365,825 | +11.5% | 0.00% | 0.0% |
| Q1 2023 | $3,779,850 | +3.7% | 328,112 | +4.3% | 0.00% | 0.0% |
| Q4 2022 | $3,646,075 | +6.9% | 314,588 | +17.2% | 0.00% | 0.0% |
| Q3 2022 | $3,410,000 | +99.6% | 268,525 | +8.0% | 0.00% | +100.0% |
| Q2 2022 | $1,708,000 | -3.3% | 248,631 | +35.6% | 0.00% | 0.0% |
| Q1 2022 | $1,767,000 | – | 183,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |